English-language podcasts

This Week in Cardiology

Nov 06, 2026 This Week in Cardiology

31 min

Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

The moderate aortic stenosis TAVR trial, blinded withdrawal in the DECISION digoxin trial, CTO-PCI vs no CTO-PCI 10-year results, and the P4 trial are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: I PROGRESS Trial PROGRESS Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607326 PROGRESS Trial Editorial https://www.nejm.org/doi/full/10.1056/NEJMe2613400 Genereux Classification https://academic.oup.com/eurheartj/article/38/45/3351/4002776 II Withdrawing Digoxin in the DECISION trial DECISION Trial Substudy https://academic.oup.com/eurheartj/article/47/38/5545/8674856 DECISION Trial - Main Trial https://www.nature.com/articles/s41591-026-04406-6 Efficacy and Safety of Digitalis Glycosides in HF: Meta-analysis https://jamanetwork.com/journals/jama/fullarticle/2848972 RADIANCE trial https://www.nejm.org/doi/full/10.1056/NEJM199307013290101 PROVED trial https://www.jacc.org/doi/10.1016/0735-1097(93)90403-N III DECISION CTO Trial at 10 Years DECISION-CTO Trial 10-Year Outcomes 10.1016/j.jacc.2026.10.068 DECISION-CTO Main paper https://doi.org/10.1161/CIRCULATIONAHA.118.031313 EURO-CTO trial https://eurointervention.pcronline.com/article/three-year-outcomes-of-eurocto-a-randomized-multicentre-trial-comparing-revascularization-and-optimal-medical-therapy-for-chronic-total-coronary-occlusions COMET-CTO trial https://pmc.ncbi.nlm.nih.gov/articles/PMC9868942/ EXPLORE Trial https://www.ahajournals.org/doi/10.1161/JAHA.123.033556 ORBITA-CTO trial https://www.jacc.org/doi/10.1016/j.jacc.2026.03.027 IV The P4 Trial Coronary CT Angiography Cuts Procedural Time Relative to IVUS-Guided PCI https://www.medscape.com/viewarticle/coronary-ct-angiography-cuts-procedural-time-relative-ivus-2026a1001684 P4 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2610771 The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact [email protected] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com/) for information about our collection and use of personal data for advertising.

Episode information is provided by the publisher. Listening takes place on the publisher’s service.

Listen at the source ↗

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

More from This Week in Cardiology

This Week in Cardiology

Nov 13, 2026 This Week in Cardiology

35 min

Listener feedback on the PROGRESS trial, the first Factor XI inhibitor improved, left bundle branch pacing, and statin discontinuation in older adults are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: I Listener Feedback PROGRESS Trial https://www.nejm.org/doi/abs/10.1056/NEJMoa2607326 II FDA Approves Asundexian in Stroke Will FDA-Approved Factor XIa Change Secondary Stroke Prevention? https://www.medscape.com/viewarticle/will-fda-approved-factor-xia-change-secondary-stroke-2026a100177u OCEANIC-STROKE Trial https://www.nejm.org/doi/10.1056/NEJMoa2513880 Bleeding With Asundexian vs Placebo in Patients With Ischemic Stroke or High-Risk TIA https://pubmed.ncbi.nlm.nih.gov/42866879/ OCEANIC-AF trial https://www.nejm.org/doi/full/10.1056/NEJMoa2407105 III Another Weak Pacing RCT – OptimPacing The Best Pacing Strategy for AV Block: A Head vs Heart Analysis of The O

Discuss this episode

Community Poll

Access to effective legal representation should not depend mainly on personal wealth.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

Your friend asks for an honest review after every date. Do their dates deserve privacy?

A close friend sends detailed post-date reports and expects your advice about every message, kiss, and awkward silence. One recent date is someone you know professionally, who would be embarrassed to learn how much you have heard.

Where does friendship's need for advice become gossip about an unsuspecting person?

Explore this quandary